The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...

Recent headlines suggest that up to 42% of people ages 55 and older face an eventual dementia diagnosis. But some experts have a follow-up message: Risk isn't the same as destiny, and there are ways ...

Discover the power of music therapy for dementia. Learn how music can reduce distress and improve well-being in institutional ...

Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the ...

Researchers at the University of Kentucky's Sanders-Brown Center on Aging are at the forefront of advancing dementia research ...

The search for answers to Alzheimer's disease and other neurodegenerative disorders remains one of the most pressing goals in brain research. Maciej J. Stawikowski, Ph.D., an assistant professor of ...

Kyung Bo Kim discovered compounds that improved cognitive function regardless of amyloid plaque buildup — an encouraging sign ...

The FDA has accepted the BLA for lecanemab-irmb SC for weekly maintenance dosing in the treatment of early Alzheimer disease.

GlobalData analysts are predicting an Alzheimer’s disease market boom, tipping its value across major regions to increase ...

A new study published in the Journal of Neurosurgery highlights the potential of focused ultrasound technology in treating ...

Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and analytics company, showed ...